- Home
- BRIA vs NVNO Comparison
BRIA vs NVNO Comparison
Compare BRIA & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRIA
- NVNO
- Stock Information
- Founded
- BRIA 2011
- NVNO 1987
- Country
- BRIA Singapore
- NVNO United States
- Employees
- BRIA N/A
- NVNO N/A
- Industry
- BRIA
- NVNO Medical/Dental Instruments
- Sector
- BRIA
- NVNO Health Care
- Exchange
- BRIA NYSE
- NVNO Nasdaq
- Market Cap
- BRIA 47.1M
- NVNO 41.0M
- IPO Year
- BRIA 2024
- NVNO N/A
- Fundamental
- Price
- BRIA $2.73
- NVNO $3.65
- Analyst Decision
- BRIA
- NVNO
- Analyst Count
- BRIA 0
- NVNO 0
- Target Price
- BRIA N/A
- NVNO N/A
- AVG Volume (30 Days)
- BRIA 29.1K
- NVNO 77.0K
- Earning Date
- BRIA 05-23-2025
- NVNO 05-01-2025
- Dividend Yield
- BRIA N/A
- NVNO N/A
- EPS Growth
- BRIA N/A
- NVNO N/A
- EPS
- BRIA 92.24
- NVNO N/A
- Revenue
- BRIA $59,695,825.00
- NVNO N/A
- Revenue This Year
- BRIA N/A
- NVNO N/A
- Revenue Next Year
- BRIA N/A
- NVNO $409.09
- P/E Ratio
- BRIA $0.03
- NVNO N/A
- Revenue Growth
- BRIA 8.03
- NVNO N/A
- 52 Week Low
- BRIA $1.78
- NVNO $2.03
- 52 Week High
- BRIA $4.38
- NVNO $6.48
- Technical
- Relative Strength Index (RSI)
- BRIA N/A
- NVNO 71.64
- Support Level
- BRIA N/A
- NVNO $2.61
- Resistance Level
- BRIA N/A
- NVNO $3.97
- Average True Range (ATR)
- BRIA 0.00
- NVNO 0.22
- MACD
- BRIA 0.00
- NVNO 0.11
- Stochastic Oscillator
- BRIA 0.00
- NVNO 80.00
About BRIA BRILLIA INC
BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.